Error: Could not add to watchlist. X

Pronova BioPharma ASA

+ Watchlist
PRON:NO
Acquired
PRON:NO was acquired by BAS:GR
NOK
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (NOK) (TTM)
0.75
Market Cap (NOK)
-
Shares Outstanding (m)
300.833
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Pronova BioPharma AS researches, develops, and manufactures marine originated omega-3 derived pharmaceutical products.
ADDRESS
PO Box 420
Lysaker, 1327
Norway
PHONE
47-22-53-48-50
  • Gert Wilhelm Munthe
    Chairman
  • Rikke Tobiasson Reinemo
    Deputy Chairman
  • Morten Jurs
    Chief Executive Officer
  • Hilde Hermansen Steineger
    VP:Business Development
  • Goeran Gannedahl
    VP:Medical & Regulatory Affair
Show More